Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $5.6B | $6.2B | $7.7B | $6.5B | $6.5B | |
Revenue Growth (YoY) | 4.57% | 10.48% | 23.61% | -15.43% | -0.43% | |
Cost of Revenues | $2.4B | $2.6B | $3B | $2.9B | $3.3B | |
Gross Profit | $3.2B | $3.6B | $4.7B | $3.6B | $3.2B | |
Gross Profit Margin | 57.55% | 57.85% | 60.99% | 54.96% | 49.63% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $846M | $844.6M | $968.7M | $1.1B | $1.2B | |
Other Inc / (Exp) | $540.3M | $496.5M | $284.6M | -$547.8M | $452.3M | |
Operating Expenses | $846M | $844.6M | $968.7M | $1.1B | $1.2B | |
Operating Income | $2.4B | $2.7B | $3.7B | $2.5B | $2B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2.9B | $3.2B | $4B | $1.9B | $2.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $678.4M | $718.9M | $896.1M | $498.6M | $654.6M | |
Net Income to Company | $2.2B | $2.5B | $3.1B | $1.4B | $1.8B | |
Minority Interest in Earnings | -$117.6M | -$150.6M | -$15.6M | $108.3M | -$47M | |
Net Income to Common Excl Extra Items | $2.1B | $2.4B | $3.1B | $1.6B | $1.8B | |
Basic EPS (Cont. Ops) | $8.82 | $10.08 | $13.25 | $6.73 | $7.78 | |
Diluted EPS (Cont. Ops) | $8.70 | $9.98 | $13.12 | $6.70 | $7.76 | |
Weighted Average Basic Share | $235.4M | $228.8M | $226.6M | $226M | $224.1M | |
Weighted Average Diluted Share | $238.6M | $231.2M | $228.8M | $227.1M | $224.8M | |
EBITDA | $2.6B | $2.9B | $3.9B | $3.1B | $2.5B | |
EBIT | $2.4B | $2.7B | $3.7B | $2.5B | $2B | |
Revenue (Reported) | $5.6B | $6.2B | $7.7B | $6.5B | $6.5B | |
Operating Income (Reported) | $2.4B | $2.7B | $3.7B | $2.5B | $2B | |
Operating Income (Adjusted) | $2.4B | $2.7B | $3.7B | $2.5B | $2B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $1.6B | $2B | $1.6B | $1.7B | $1.8B | |
Revenue Growth (YoY) | 11.85% | 22.45% | -18.73% | 5.2% | 6.88% | |
Cost of Revenues | $662.6M | $730.9M | $733.6M | $784.4M | $844.9M | |
Gross Profit | $933.2M | $1.2B | $854.6M | $886.3M | $940.7M | |
Gross Profit Margin | 58.48% | 62.6% | 53.81% | 53.05% | 52.68% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $204.3M | $227M | $282.8M | $266.5M | $289M | |
Other Inc / (Exp) | $191.6M | -$11.5M | -$80M | -$35.7M | $174.4M | |
Operating Expenses | $204.3M | $227M | $282.8M | $266.5M | $289M | |
Operating Income | $728.9M | $996.2M | $571.8M | $619.8M | $651.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $920.5M | $984.7M | $491.8M | $584.1M | $826.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $221.9M | $227.3M | $134M | $144.9M | $185.7M | |
Net Income to Company | $698.6M | $757.4M | $357.8M | $439.2M | $640.4M | |
Minority Interest in Earnings | -$55.4M | $19.8M | $26.6M | $14M | -$37.4M | |
Net Income to Common Excl Extra Items | $643.2M | $777.2M | $384.4M | $453.2M | $603M | |
Basic EPS (Cont. Ops) | $2.75 | $3.34 | $1.67 | $1.98 | $2.64 | |
Diluted EPS (Cont. Ops) | $2.73 | $3.31 | $1.66 | $1.97 | $2.64 | |
Weighted Average Basic Share | $227M | $226.9M | $225.3M | $224.1M | $222.3M | |
Weighted Average Diluted Share | $229.4M | $229.1M | $226.3M | $224.8M | $222.8M | |
EBITDA | $778.6M | $1B | $628.6M | $619.8M | $651.7M | |
EBIT | $728.9M | $996.2M | $571.8M | $619.8M | $651.7M | |
Revenue (Reported) | $1.6B | $2B | $1.6B | $1.7B | $1.8B | |
Operating Income (Reported) | $728.9M | $996.2M | $571.8M | $619.8M | $651.7M | |
Operating Income (Adjusted) | $728.9M | $996.2M | $571.8M | $619.8M | $651.7M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $5.9B | $7.4B | $6.9B | $6.3B | $6.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.5B | $2.9B | $2.9B | $3.2B | $3.4B | |
Gross Profit | $3.4B | $4.5B | $4B | $3.1B | $3.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $878.2M | $903.7M | $1.1B | $1.1B | $1.2B | |
Other Inc / (Exp) | $276.4M | $624.6M | -$466.8M | $193.2M | $598M | |
Operating Expenses | $878.2M | $903.7M | $1.1B | $1.1B | $1.2B | |
Operating Income | $2.6B | $3.6B | $2.9B | $2B | $2.3B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2.8B | $4.2B | $2.5B | $2.2B | $2.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $658.9M | $933.5M | $578.4M | $580.5M | $700.8M | |
Net Income to Company | $2.2B | $3.3B | $1.9B | $1.7B | $2.2B | |
Minority Interest in Earnings | -$53M | -$168.8M | $138.9M | -$34.6M | -$94.9M | |
Net Income to Common Excl Extra Items | $2.1B | $3.1B | $2B | $1.6B | $2.1B | |
Basic EPS (Cont. Ops) | $9.03 | $13.40 | $8.78 | $7.04 | $9.16 | |
Diluted EPS (Cont. Ops) | $8.93 | $13.27 | $8.71 | $7.02 | $9.14 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2.8B | $3.8B | $3.2B | $2.7B | $2.8B | |
EBIT | $2.6B | $3.6B | $2.9B | $2B | $2.3B | |
Revenue (Reported) | $5.9B | $7.4B | $6.9B | $6.3B | $6.9B | |
Operating Income (Reported) | $2.6B | $3.6B | $2.9B | $2B | $2.3B | |
Operating Income (Adjusted) | $2.6B | $3.6B | $2.9B | $2B | $2.3B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $4.5B | $5.7B | $5B | $4.8B | $5.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.9B | $2.2B | $2.1B | $2.4B | $2.5B | |
Gross Profit | $2.6B | $3.5B | $2.9B | $2.4B | $2.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $622.8M | $681.9M | $791M | $824M | $859.7M | |
Other Inc / (Exp) | $106.4M | $234.5M | -$516.9M | $224.1M | $369.8M | |
Operating Expenses | $622.8M | $681.9M | $791M | $824M | $859.7M | |
Operating Income | $2B | $2.8B | $2.1B | $1.6B | $1.9B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2.1B | $3.1B | $1.6B | $1.8B | $2.2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $502.5M | $717.1M | $399.4M | $481.3M | $527.5M | |
Net Income to Company | $1.6B | $2.4B | $1.2B | $1.4B | $1.7B | |
Minority Interest in Earnings | -$4.4M | -$22.6M | $131.9M | -$11M | -$58.9M | |
Net Income to Common Excl Extra Items | $1.6B | $2.3B | $1.3B | $1.4B | $1.7B | |
Basic EPS (Cont. Ops) | $6.76 | $10.04 | $5.57 | $5.88 | $7.25 | |
Diluted EPS (Cont. Ops) | $6.69 | $9.94 | $5.53 | $5.86 | $7.24 | |
Weighted Average Basic Share | $688.5M | $681.5M | $680.2M | $672.9M | $668.9M | |
Weighted Average Diluted Share | $695.7M | $688.3M | $684M | $675.2M | $670.5M | |
EBITDA | $2.1B | $3B | $2.2B | $1.8B | $2.1B | |
EBIT | $2B | $2.8B | $2.1B | $1.6B | $1.9B | |
Revenue (Reported) | $4.5B | $5.7B | $5B | $4.8B | $5.3B | |
Operating Income (Reported) | $2B | $2.8B | $2.1B | $1.6B | $1.9B | |
Operating Income (Adjusted) | $2B | $2.8B | $2.1B | $1.6B | $1.9B |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.8B | $2.2B | $1.5B | $1.8B | $2.1B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $646.6M | $863.1M | $1.1B | $748.7M | $807.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.4B | $3B | $2.6B | $2.5B | $2.9B | |
Property Plant And Equipment | $785.2M | $813M | $937.4M | $1B | $1B | |
Long-Term Investments | $5.2B | $5.9B | $4.9B | $3.4B | $3.7B | |
Goodwill | $665.7M | $665.7M | $2.7B | $2.6B | $2.6B | |
Other Intangibles | -- | -- | $913.4M | $629.8M | $507.3M | |
Other Long-Term Assets | $234.4M | $219.2M | $445.3M | $688.7M | $692.5M | |
Total Assets | $9.3B | $10.7B | $12.5B | $11.6B | $12.3B | |
Accounts Payable | $214.5M | $187.7M | $431M | $406.7M | $409.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $246.3M | $272.7M | $508.9M | $452.7M | $475.7M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.4B | $2.3B | $2B | $2B | |
Common Stock | $47M | $45.6M | $45.8M | $44.9M | $44.8M | |
Other Common Equity Adj | -$43M | -$23M | -$26.5M | -$53M | -$47.5M | |
Common Equity | $7.1B | $7.7B | $9B | $8.8B | $9.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.1B | $1.6B | $1.2B | $847.4M | $786.1M | |
Total Equity | $8.2B | $9.3B | $10.3B | $9.7B | $10.3B | |
Total Liabilities and Equity | $9.3B | $10.7B | $12.5B | $11.6B | $12.3B | |
Cash and Short Terms | $1.8B | $2.2B | $1.5B | $1.8B | $2.1B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.2B | $3.4B | $2.4B | $2.6B | $3.2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $714.8M | $941.6M | $741.4M | $752M | $890M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.9B | $4.4B | $3.1B | $3.3B | $4.1B | |
Property Plant And Equipment | $821.1M | $825.3M | $1B | $1B | $1.2B | |
Long-Term Investments | $5.5B | $5.4B | $3.8B | $4.3B | $3.9B | |
Goodwill | $665.7M | $665.7M | $2.7B | $2.6B | $2.6B | |
Other Intangibles | -- | -- | $832M | $542.4M | $395.2M | |
Other Long-Term Assets | $231.7M | $242.6M | $601M | $709.4M | $622.6M | |
Total Assets | $10.1B | $11.5B | $12B | $12.6B | $13.7B | |
Accounts Payable | $186.9M | $309.8M | $382.8M | $395.2M | $359.1M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $253.6M | $370.5M | $421.1M | $437.6M | $372.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $2.1B | $2.3B | $2.4B | $2.5B | |
Common Stock | $45.3M | $45.2M | $44.8M | $44.7M | $44.4M | |
Other Common Equity Adj | -$42.7M | -$29.4M | -$56.5M | -$46.2M | -$39.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.3B | $1.1B | $787.8M | $781.7M | $966.8M | |
Total Equity | $8.5B | $9.3B | $9.7B | $10.2B | $11.2B | |
Total Liabilities and Equity | $10.1B | $11.5B | $12B | $12.6B | $13.7B | |
Cash and Short Terms | $2.2B | $3.4B | $2.4B | $2.6B | $3.2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.2B | $2.5B | $3.1B | $1.4B | $1.8B | |
Depreciation & Amoritzation | $190.8M | $189.6M | $204.8M | $645.8M | $481.6M | |
Stock-Based Compensation | $206.6M | $246.2M | $274.6M | $285.4M | $265.6M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.5B | $1.9B | $3.5B | $2.4B | $1.2B | |
Capital Expenditures | $204.6M | $214.6M | $239.1M | $237.6M | $307.9M | |
Cash Acquisitions | -- | -- | -$2.5B | -- | -- | |
Cash From Investing | -$324.5M | -$36.3M | -$1.1B | -$41.5M | $128.2M | |
Dividends Paid (Ex Special Dividend) | -$733.9M | -$845.8M | -$1.7B | -$1.1B | -$1.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$705.8M | -$1.2B | -$1.1B | -$849.8M | -$254.4M | |
Other Financing Activities | $523.7M | $557.5M | -$66.8M | -$83.5M | $315.5M | |
Cash From Financing | -$832.7M | -$1.5B | -$3B | -$2.1B | -$1.1B | |
Beginning Cash (CF) | $1.5B | $1.9B | $2.3B | $1.6B | $1.9B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $365.5M | $396.3M | -$634.9M | $241M | $268.7M | |
Ending Cash (CF) | $1.9B | $2.3B | $1.6B | $1.9B | $2.1B | |
Levered Free Cash Flow | $1.3B | $1.7B | $3.2B | $2.1B | $911.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $929.6M | $733.6M | $289.6M | $473.6M | -- | |
Depreciation & Amoritzation | $45.6M | $53.7M | $479.8M | $300M | -- | |
Stock-Based Compensation | $81.7M | $108.3M | $99.7M | $95.9M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2M | $361.3M | -$135.2M | -$157.4M | -- | |
Capital Expenditures | $59.2M | $60.4M | $60.4M | $81.9M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $16.8M | -$1.2B | $28M | $90.1M | -- | |
Dividends Paid (Ex Special Dividend) | -$210.1M | -$247.9M | -$275M | -$279.7M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$43.4M | -$645.4M | -$121.9M | -$113.2M | -- | |
Other Financing Activities | $258.8M | -$89.5M | -$13.3M | -$25M | -- | |
Cash From Financing | -$67M | -$1.1B | -$460.2M | -$461.4M | -- | |
Beginning Cash (CF) | $2.3B | $3.5B | $2.4B | $2.7B | -- | |
Foreign Exchange Rate Adjustment | -$1.5M | $6.2M | -$2.3M | $2.2M | -- | |
Additions / Reductions | -$48.2M | -$1.9B | -$567.4M | -$528.7M | -- | |
Ending Cash (CF) | $2.3B | $1.6B | $1.9B | $2.1B | -- | |
Levered Free Cash Flow | -$57.2M | $300.9M | -$195.6M | -$239.3M | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.2B | $3.3B | $1.9B | $1.7B | $2.2B | |
Depreciation & Amoritzation | $203.1M | $196.7M | $219.7M | $661.4M | $488.4M | |
Stock-Based Compensation | $235M | $248M | $294M | $269.4M | $258.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.9B | $3.1B | $2.9B | $1.2B | $1.8B | |
Capital Expenditures | $211.1M | $237.9M | $237.6M | $286.4M | $392.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$300.9M | $74.4M | -$1.2B | $66.1M | -$64.9M | |
Dividends Paid (Ex Special Dividend) | -$819.2M | -$1.7B | -$1.1B | -$1.1B | -$1.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$1.3B | -$536.5M | -$1.4B | -$263.1M | -$382.3M | |
Other Financing Activities | $435.3M | $281.5M | -$159.7M | $327.2M | $338.8M | |
Cash From Financing | -$1.6B | -$2B | -$2.7B | -$1.1B | -$1.2B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9M | $1.2B | -$1.1B | $230M | $555.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.7B | $2.9B | $2.6B | $954.9M | $1.4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.5B | $3.1B | $1.4B | $1.8B | $1.7B | |
Depreciation & Amoritzation | $189.6M | $204.8M | $645.8M | $481.6M | $188.4M | |
Stock-Based Compensation | $246.2M | $274.6M | $285.4M | $265.6M | $162.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.9B | $3.5B | $2.4B | $1.2B | $2B | |
Capital Expenditures | $214.6M | $239.1M | $237.6M | $307.9M | $310.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$36.3M | -$1.1B | -$41.5M | $128.2M | -$155M | |
Dividends Paid (Ex Special Dividend) | -$845.8M | -$1.7B | -$1.1B | -$1.1B | -$851M | |
Special Dividend Paid | -- | $3M | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$1.2B | -$1.1B | -$849.8M | -$254.4M | -$269.1M | |
Other Financing Activities | $557.5M | -$66.8M | -$83.5M | $315.5M | $363.8M | |
Cash From Financing | -$1.5B | -$3B | -$2.1B | -$1.1B | -$728.2M | |
Beginning Cash (CF) | $8B | $12.3B | $8.3B | $9.1B | $7.4B | |
Foreign Exchange Rate Adjustment | $1.9M | $2.6M | $9.5M | $400K | $500K | |
Additions / Reductions | $396.3M | -$634.9M | $241M | $268.7M | $1.1B | |
Ending Cash (CF) | $8.4B | $11.6B | $8.6B | $9.3B | $8.5B | |
Levered Free Cash Flow | $1.7B | $3.2B | $2.1B | $911.2M | $1.7B |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.